Novel GCH-1 mutations and unusual long-lasting dyskinesias in Korean families with dopa-responsive dystonia.

Abstract

OBJECTIVE:

To describe the long-term follow-up data of Korean patients with GTP cyclohydrolase (GTPCH) I deficient dopa-responsive dystonia (DRD) with novel mutations and unusual long-lasting dyskinesias.

METHODS:

Clinical features and genetic testing results of GCH1 from 19 patients that included 4 families who have been followed-up for up to 25 years were analyzed.

RESULTS:

GCH1 mutations were confirmed in all our symptomatic subjects including 3 novel point mutations. All the subjects except for one family had typical manifestations of autosomal dominant GTPCH-I deficient DRD including early childhood onset dystonia predominantly in the legs, marked diurnal variation, intact cognition, no other systemic symptoms, and excellent sustained response to levodopa. The one family who was the exception had two gene positive members of DRD and one with dopa-unresponsive cervical dystonia with negative GCH1 mutation. One family and a sporadic case had been reported as gene negative in a previous study, but they typically had preserved dopamine transporter binding and low neopterin levels in cerebrospinal fluids; thus, GCH-1 mutation had been highly suspected, which was now confirmed by repeating the genetic testing this time. An early childhood-onset patient developed choreiform dyskinesias right after administration of levodopa. The dyskinesia had lasted for more than 4 years regardless of the levodopa dosages and then subsided while maintaining levodopa.

CONCLUSION:

This report emphasizes the usefulness of the neopterin level in cerebrospinal fluids and dopamine transporter imaging in the differential diagnosis of DRD syndromes and a possible mechanism of levodopa-induced-dyskinesia in early childhood onset case.

• Authors: Jee-Young Lee, Hee Joon Yang, Jong-Min Kim, Beom S Jeon
• Journal: Parkinsonism & related disorders (Parkinsonism Relat Disord) Vol. 19 Issue 12 Pg. 1156-9 (Dec 2013) ISSN: 1873-5126 [Electronic] England
• PMID: 24018121 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2013 Elsevier Ltd. All rights reserved.

Chemical References

• Dopamine Agents
• Levodopa
• GTP Cyclohydrolase

Topics

• Adolescent
• Adult
• Age of Onset
• Asian People (genetics)
• Child
• Child, Preschool
• Dopamine Agents (therapeutic use)
• Dyskinesias (drug therapy, etiology, genetics)
• Dystonic Disorders (complications, drug therapy, genetics)
• Family
• Female
• GTP Cyclohydrolase (genetics)
• Humans
• Infant
• Levodopa (therapeutic use)
• Male
• Middle Aged
• Mutation
• Pedigree
• Phenylketonurias (complications, drug therapy, genetics)
• Young Adult